Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chronic hepatitis B virus (HBV) infection in pregnancy.

Hepatology international·2009
Same author

Is the prognosis of young patients with hepatocellular carcinoma poorer than the prognosis of older patients? A comparative analysis of clinical characteristics, prognostic features, and survival outcome.

Journal of gastroenterology·2008
Same author

Treatment of chronic hepatitis C in patients with end-stage renal disease and hemophilia--the Singapore experience.

Intervirology·2005
See all related articles

Related Experiment Video

Updated: May 28, 2026

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
09:49

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization

Published on: December 2, 2013

Screening for hepatocellular carcinoma.

Hock-Foong Lui1

  • 1Gleneagles Hospital, 6A Napier Road, Singapore 258500.

International Journal of Hepatology
|October 27, 2011
PubMed
Summary
This summary is machine-generated.

Early screening for hepatocellular carcinoma (HCC) is crucial for improving outcomes in patients with chronic liver disease. Regular ultrasound and alpha-fetoprotein tests are the current standard for detecting this lethal cancer in at-risk individuals.

More Related Videos

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma
08:25

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma

Published on: April 25, 2025

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

Related Experiment Videos

Last Updated: May 28, 2026

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
09:49

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization

Published on: December 2, 2013

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma
08:25

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma

Published on: April 25, 2025

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

Area of Science:

  • Hepatology
  • Oncology
  • Medical Diagnostics

Background:

  • Hepatocellular carcinoma (HCC) is a severe complication of chronic liver disease.
  • It ranks as the third most lethal cancer globally, often diagnosed late.
  • Late diagnosis leads to poor patient outcomes.

Purpose of the Study:

  • To emphasize the critical role of screening in managing hepatocellular carcinoma.
  • To outline the essential components of a successful HCC screening program.
  • To identify the at-risk populations for hepatocellular carcinoma.

Main Methods:

  • The study focuses on the established screening protocol for HCC.
  • This protocol involves regular surveillance of at-risk populations.
  • Key diagnostic tools include ultrasound and alpha-fetoprotein (AFP) testing.

Main Results:

  • Patients with liver cirrhosis or chronic hepatitis B virus infection are identified as high-risk groups.
  • A six-monthly screening schedule using ultrasound and AFP is the current standard.
  • While new diagnostic methods show potential, they have not replaced existing tests.

Conclusions:

  • Screening is paramount for effective hepatocellular carcinoma treatment.
  • The current standard screening involves biannual ultrasound and AFP tests.
  • Early detection through screening offers a better prognosis for HCC patients.